A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.

CompletedOBSERVATIONAL
Enrollment

1,338

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Severe Pain
Interventions
DRUG

Targinact® (oxycodone/naloxone)

Trial Locations (1)

Unknown

University Hospital Antwerp (UZA):, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mundipharma CVA

OTHER

NCT01983137 - A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain. | Biotech Hunter | Biotech Hunter